ANTH

Anthera Pharmaceuticals, Inc. News Headlines

$5.2
*  
0.31
6.34%
Get ANTH Alerts
*Delayed - data as of Apr. 24, 2015  -  Find a broker to begin trading ANTH now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By







Anthera Shifts Its Strategy For Blisibimod
1/23/2013 11:56:00 AM - Seeking Alpha




Anthera Recovering After Long Fall
11/27/2012 10:39:00 AM - Seeking Alpha




GlaxoSmithKline: Buy For 4.5% Yield
10/8/2012 10:03:00 AM - Seeking Alpha


Pick Biotech Winners Like A Pro: John McCamant
10/5/2012 1:03:00 PM - Seeking Alpha








Biotech Class Of 2010: IPOs Revisited
1/4/2012 3:37:00 PM - Seeking Alpha


8 Oversold Healthcare Stocks Being Bought Up By Insiders
9/20/2011 2:59:00 AM - Seeking Alpha


10 Most Popular Drug Companies That Hedge Funds Love
8/26/2011 10:51:00 AM - Seeking Alpha


8 Oversold Small Caps Insiders Are Buying
8/3/2011 4:29:00 PM - Seeking Alpha




7 Small-Cap Biotechs With Bullish Insider Buying in 2011
6/12/2011 5:50:00 AM - Seeking Alpha






Anthera's Lead Drug: A High-Risk, High-Reward Proposition
6/27/2010 8:32:00 AM - Seeking Alpha


Biotech Deal Activity Takes a Breather
4/4/2010 4:20:00 AM - Seeking Alpha


March Roars in for Life Sciences
3/8/2010 1:54:00 AM - Seeking Alpha


Anthera Off to a Humble Start
3/7/2010 4:10:00 AM - Seeking Alpha